Lawsuit Says Trader Joe’s “Low Acid” Coffee Was Too Low on Caffeine

Key Takeaways

• Trader Joe’s “French Roast Low Acid” contains half the caffeine of regular coffee
• Federal class action filed in Central District of California on April 23, 2026
• Puroast testing shows Trader Joe’s coffee has 45‑51% caffeine of standard blends
• Complaint claims labeling misleads consumers about caffeine content and acidity
• Trader Joe’s has not responded; litigation remains ongoing

Pulse Analysis

The low‑acid coffee niche has surged as health‑conscious drinkers seek smoother brews without the stomach irritation that higher acidity can cause. Trader Joe’s entered this space with its “French Roast Low Acid” whole‑bean offering, promoting a “smooth & full‑flavored” experience while implying full caffeine strength. However, laboratory analysis referenced in the new class action reveals caffeine levels comparable to half‑caff products, raising questions about whether the brand’s marketing aligns with consumer expectations for energy‑boosting coffee.

From a legal perspective, the complaint leans on the Federal Trade Commission’s guidelines that prohibit deceptive claims about product attributes, including caffeine content. By invoking the earlier Puroast litigation—where similar testing exposed reduced caffeine levels—plaintiffs argue Trader Joe’s had constructive notice of the discrepancy. If courts find the labeling misleading, Trader Joe’s could face damages, mandatory relabeling, and heightened oversight, echoing outcomes seen in other food‑and‑beverage false‑advertising cases.

Beyond the immediate lawsuit, the case could trigger broader industry reverberations. Coffee retailers may tighten testing protocols and revise packaging language to clearly differentiate low‑acid, half‑caff, and fully caffeinated products. Consumers, increasingly savvy about ingredient claims, might demand greater transparency, prompting brands to adopt more precise labeling standards. For Trader Joe’s, the dispute underscores the risk of conflating health‑focused descriptors with performance expectations, a balance that will shape coffee marketing strategies in the years ahead.